Healthcare provider profile · identity verified

Justine Kostrub, MD

Family Practice · SEWICKLEY, PA · NPI 1386057776

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	366	119
Levothyroxine Sodium	Levothyroxine Sodium	353	99
Lisinopril	Lisinopril	326	116
Amlodipine Besylate	Amlodipine Besylate	289	97
Simvastatin	Simvastatin	257	88
Losartan Potassium	Losartan Potassium	200	65
Metoprolol Succinate	Metoprolol Succinate	190	53
Omeprazole	Omeprazole	178	65
Metformin Hcl	Metformin Hcl	167	55
Gabapentin	Gabapentin	165	49
Fluoxetine Hcl	Fluoxetine Hcl	163	47
Atenolol	Atenolol	153	55
Rosuvastatin Calcium	Rosuvastatin Calcium	147	56
Hydrochlorothiazide	Hydrochlorothiazide	124	38
Pravastatin Sodium	Pravastatin Sodium	121	39
Albuterol Sulfate Hfa	Albuterol Sulfate	110	44
Potassium Chloride	Potassium Chloride	108	30
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	93	29
Valsartan	Valsartan	89	32
Escitalopram Oxalate	Escitalopram Oxalate	87	22
Eliquis	Apixaban	83	21
Alendronate Sodium	Alendronate Sodium	77	26
Tamsulosin Hcl	Tamsulosin Hcl	71	23
Furosemide	Furosemide	69	27
Pantoprazole Sodium	Pantoprazole Sodium	66	27
Donepezil Hcl	Donepezil Hcl	62	16
Fluticasone Propionate	Fluticasone Propionate	60	29
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	60	21
Oxybutynin Chloride Er	Oxybutynin Chloride	60	19
Allopurinol	Allopurinol	59	18
Sertraline Hcl	Sertraline Hcl	57	20
Metoprolol Tartrate	Metoprolol Tartrate	53	17
Duloxetine Hcl	Duloxetine Hcl	52	17
Meloxicam	Meloxicam	51	15
Trazodone Hcl	Trazodone Hcl	50	suppressed
Ipratropium Bromide	Ipratropium Bromide	48	37
Ozempic	Semaglutide	48	15
Buspirone Hcl	Buspirone Hcl	47	12
Synthroid	Levothyroxine Sodium	41	12
Benazepril Hcl	Benazepril Hcl	39	12
Bupropion Xl	Bupropion Hcl	39	12
Esomeprazole Magnesium	Esomeprazole Magnesium	39	11
Irbesartan	Irbesartan	39	suppressed
Jardiance	Empagliflozin	39	17
Montelukast Sodium	Montelukast Sodium	38	15
Xarelto	Rivaroxaban	38	13
Diclofenac Sodium	Diclofenac Sodium	37	17
Famotidine	Famotidine	37	13
Mirtazapine	Mirtazapine	37	14
Prednisone	Prednisone	34	28
Triamcinolone Acetonide	Triamcinolone Acetonide	34	17
Nystatin	Nystatin	33	15
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	33	24
Alprazolam	Alprazolam	31	suppressed
Glipizide Er	Glipizide	29	suppressed
Carvedilol	Carvedilol	28	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	26	16
Ropinirole Hcl	Ropinirole Hcl	26	suppressed
Valacyclovir	Valacyclovir Hcl	26	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	26	suppressed
Azelastine Hcl	Azelastine Hcl	25	13
Bumetanide	Bumetanide	25	suppressed
Azithromycin	Azithromycin	24	22
Metformin Hcl Er	Metformin Hcl	24	suppressed
Breo Ellipta	Fluticasone/Vilanterol	23	suppressed
Cephalexin	Cephalexin	23	19
Citalopram Hbr	Citalopram Hydrobromide	23	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	23	suppressed
Tramadol Hcl	Tramadol Hcl	22	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	22	12
Clopidogrel	Clopidogrel Bisulfate	21	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	20	suppressed
Ibuprofen	Ibuprofen	20	suppressed
Trulicity	Dulaglutide	20	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	19	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	19	suppressed
Ezetimibe	Ezetimibe	19	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	18	15
Colestipol Hcl	Colestipol Hcl	18	suppressed
Fluconazole	Fluconazole	18	14
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	18	suppressed
Ondansetron Odt	Ondansetron	18	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	18	suppressed
Januvia	Sitagliptin Phosphate	17	suppressed
Ketoconazole	Ketoconazole	17	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	17	suppressed
Lorazepam	Lorazepam	17	16
Topiramate	Topiramate	17	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	17	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	16	suppressed
Memantine Hcl Er	Memantine Hcl	16	suppressed
Spironolactone	Spironolactone	16	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	16	suppressed
Bupropion Hcl Sr	Bupropion Hcl	15	suppressed
Divalproex Sodium	Divalproex Sodium	15	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	15	11
Oxybutynin Chloride	Oxybutynin Chloride	15	suppressed
Risperidone	Risperidone	15	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	15	suppressed
Felodipine Er	Felodipine	14	suppressed
Finasteride	Finasteride	14	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	14	suppressed
Lamotrigine	Lamotrigine	14	suppressed
Meclizine Hcl	Meclizine Hcl	14	suppressed
Pregabalin	Pregabalin	14	suppressed
Sucralfate	Sucralfate	14	suppressed
Baclofen	Baclofen	13	suppressed
Hydralazine Hcl	Hydralazine Hcl	13	suppressed
Nuedexta	Dextromethorphan Hbr/Quinidine	13	suppressed
Ventolin Hfa	Albuterol Sulfate	13	suppressed
Amoxicillin	Amoxicillin	12	suppressed
Aripiprazole	Aripiprazole	12	suppressed
Benztropine Mesylate	Benztropine Mesylate	12	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	12	12
Fluticasone Propionate Hfa	Fluticasone Propionate	12	suppressed
Fluvoxamine Maleate	Fluvoxamine Maleate	12	suppressed
Oxycodone Hcl	Oxycodone Hcl	12	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	12	suppressed
Ondansetron Hcl	Ondansetron Hcl	11	suppressed
Repaglinide	Repaglinide	11	suppressed
Risperidone Odt	Risperidone	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error